Assessment of Asthma Control Level in Primary Care Setting in Malaysia (ASCOPE)

AstraZeneca

Status: Completed

Conditions: Asthma Control Level

Study type: Observational

Funder types: Industry

Identifiers

NCT03804632

D2287R00120

Details and patient eligibility

About

A prospective observational multi center study to assess the level of asthma control at Primary Care Setting; government health clinics (Klinik Kesihatan) in Malaysia. The specific objective of the study is to assess, in real-life clinical practice in Malaysia, the level of asthma control and the potential risk factors for uncontrolled disease in asthma patients treated at government health clinics.

Full description

Despite the availability of GINA global guideline on asthma management which is widely referred by health care providers in Malaysia, the control of asthma is still a critical challenge. According to National Health and Morbidity Survey 2011, the prevalence of asthma in Malaysia is at 6.3%. Based on self-rated health status, 5.5% of patients were reported to be in good health whereas 9.9% reported poor health status although medications such as inhaled corticosteroids (ICS) and long-acting beta agonists (LABA) are widely available for effective asthma management. There is limited data to assess the level of asthma control at the Primary Care Setting in Malaysia which includes current clinical manifestation and future risk of exacerbation. Given the lack of data on Asthma control level, the awareness on the current disease control level will assist to properly characterise the patients based on GINA control level thus leading to appropriate diagnosis and treatment. The specific objective of the study is to assess, in real-life clinical practice in Malaysia, the level of GINA-defined asthma control and the potential risk factors for uncontrolled disease in asthma patients.

Enrollment: 1,011 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Malaysians who have been diagnosed with Asthma by a physician verified by an investigator and seen at government health clinic (Klinik Kesihatan) from October - December 2017
• Be at least 18 years of age

Exclusion criteria

• Clinical features suggesting emphysema or chronic bronchitis and other chronic lung diagnosis
• Pregnancy

Trial design

1,011 participants in 1 patient group

GINA-defined clinical diagnosis of Asthma

Description:

All patients with GINA-defined clinical diagnosis of Asthma seen at respiratory clinic from October to December 2017 with age 18 and above